Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000038721 | SCV000062399 | likely benign | not specified | 2013-01-23 | criteria provided, single submitter | clinical testing | Pro439Pro in exon 12 of LDB3: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. Pro439Pro in exon 12 of LDB3 (allele frequenc y = n/a) |
Labcorp Genetics |
RCV001469724 | SCV001673810 | likely benign | Myofibrillar myopathy 4 | 2023-09-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003421953 | SCV004127013 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | LDB3: BP4, BP7 |
Prevention |
RCV003924935 | SCV004740421 | likely benign | LDB3-related disorder | 2019-05-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |